Business Context and Reporting Period
Company: Brookfield Corporation
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter ended September 30, 2024
Filing Date: November 14, 2024
This filing serves as a cover document incorporating by reference the Management's Discussion and Analysis (MD&A) and Unaudited Interim Consolidated Financial Statements for the quarter ended September 30, 2024. The detailed financial data is contained in Exhibit 99.1 (Interim Report to Shareholders), pages 10 to 94.
Key Financial Metrics
The provided text is a cover filing and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located within the incorporated Exhibit 99.1, which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the MD&A in Exhibit 99.1 for comparative analysis.
Guidance, Outlook, and Risks
Guidance and Outlook: No specific guidance or outlook commentary is present in the cover text.
Risks and Contingencies: No specific risks or contingencies are detailed in this document.
Unusual Items: No unusual items are described in the provided text.
Important Facts for Investor Verification
- Source of Data: All financial results and management commentary for the quarter ended September 30, 2024, are located in Exhibit 99.1 (Interim Report to Shareholders), not in the Form 6-K text itself.
- Registration Statements: The MD&A and financial statements are incorporated by reference into multiple registration statements on Forms F-3, S-8, and F-10 for Brookfield Corporation and its finance subsidiaries.
- Signatory: The report was signed by Swati Mandava, Managing Director, Legal & Regulatory, on November 14, 2024.
- Missing Numerical Data: The input text does not provide clear values for revenue, earnings, or balance sheet items; these must be extracted from the referenced Exhibit 99.1.